Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors. (CROSBI ID 581091)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Trivanovic, Dragan ; Plestina, Stjepko ; Jerin, Lems ; Honovic, Lorena An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors. // Journal of Clinical Oncology. 2011

Podaci o odgovornosti

Trivanovic, Dragan ; Plestina, Stjepko ; Jerin, Lems ; Honovic, Lorena

engleski

An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors.

An open-label randomized phase II trial of oral vitamin D3 supplementation in combination with standard chemotherapy or best supportive care compared with standard chemotherapy and best supportive care in patients with advanced solid tumors.

vitamin D; solid tumors

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2011.

objavljeno

Podaci o matičnoj publikaciji

Journal of Clinical Oncology

Podaci o skupu

ASCO Annual Meeting 2011

poster

03.06.2011-07.06.2011

Chicago (IL), Sjedinjene Američke Države

Povezanost rada

Kliničke medicinske znanosti